Joseph Adriana M, Manseau Marc W, Lalane Monique, Rajparia Amit, Lewis Crystal Fuller
a The Nathan Kline Institute, Research Foundation for Mental Hygiene , Orangeburg , NY , USA.
b New York University School of Medicine , Department of Psychiatry , One Park Avenue, New York , NY, USA.
Am J Drug Alcohol Abuse. 2017 Jan;43(1):117-122. doi: 10.1080/00952990.2016.1240799. Epub 2016 Oct 31.
Growing evidence of adverse outcomes following synthetic cannabinoid use has engendered interest into populations at risk. The existing literature reports that synthetic cannabinoid use is predominant among young, white males. However, reports from local Departments of Health have found contrary evidence, showing that synthetic cannabinoid use is prevalent in populations other than those of young, white men.
This study sought to examine sociodemographic characteristics associated with self-reported synthetic cannabinoid use among a clinical psychiatric population within a public hospital in New York City.
A cross-sectional medical record review was conducted on synthetic cannabinoid users and non-users in an emergency psychiatric setting. A total of 948 patients who presented at the emergency psychiatric setting in 2014 were included in this sample, 110 (11.6%) of whom were synthetic cannabinoid users. Logistic regressions were used to determine the sociodemographic correlates of synthetic cannabinoid use.
The most prominent correlate of synthetic cannabinoid use was homelessness/residing in a shelter during time of treatment (AOR = 17.77, 95% CI = 9.74-32.5). Male (AOR = 5.37, 95% CI = 2.04-14.1), non-white (AOR = 2.74, 95% CI = 1.36-5.54), and younger age (AOR = .961, 95% CI = .940-.980) were also significant correlates of synthetic cannabinoid use.
Synthetic cannabinoid use among the homeless and mentally ill is a growing public health concern, representing a population with unique clinical and social needs. Areas and populations with high rates of homelessness should be targeted for synthetic cannabinoid prevention and treatment efforts, particularly in urban and racial/ethnic minority communities.
越来越多的证据表明使用合成大麻素会产生不良后果，这引发了人们对高危人群的关注。现有文献报道，合成大麻素的使用在年轻白人男性中最为普遍。然而，当地卫生部门的报告却发现了相反的证据，表明合成大麻素的使用在年轻白人男性以外的人群中也很普遍。
本研究旨在调查纽约市一家公立医院临床精神科人群中与自我报告的合成大麻素使用相关的社会人口学特征。
在急诊精神科环境中，对合成大麻素使用者和非使用者进行了横断面病历审查。本样本纳入了2014年在急诊精神科就诊的948名患者，其中110名（11.6%）为合成大麻素使用者。采用逻辑回归分析来确定合成大麻素使用的社会人口学相关因素。
合成大麻素使用最显著的相关因素是在治疗期间无家可归/居住在收容所（比值比[AOR]=17.77，95%置信区间[CI]=9.74 - 32.5）。男性（AOR = 5.37，95% CI = 2.04 - 14.1）、非白人（AOR = 2.74，95% CI = 1.36 - 5.54）和较年轻的年龄（AOR = 0.961，95% CI = 0.940 - 0.980）也是合成大麻素使用的显著相关因素。
无家可归者和精神病患者中合成大麻素的使用是一个日益严重的公共卫生问题，这一人群有着独特的临床和社会需求。应将无家可归率高的地区和人群作为合成大麻素预防和治疗工作的目标，特别是在城市和种族/族裔少数群体社区。
